Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: TimF who wrote (528714)	11/13/2009 1:00:30 PM
From: Peter Dierks	Respond to of 1575913

Hillary's Vaccine Shortage Here is another story about it: Message 19592745

To: TimF who wrote (528714)	11/13/2009 1:19:09 PM
From: tejek	Read Replies (1) \| Respond to of 1575913

A paper prepared by members of the medical community for peer review: Abstract: Vaccine shortages can result from higher-than-expected demand, interruptions in production/supply, or a lack of resources to purchase vaccines. Each of these factors has played a role in vaccine shortages in the United States during the past 20 years. Since 2000, the United States has experienced an unprecedented series of shortages of vaccines recommended for widespread use against 9 diseases, after more than 15 years without vaccine supply problems. In developing countries, the major cause of vaccine shortages is lack of resources to purchase them. Although there are several steps that could reduce the likelihood of future vaccine shortages, many would take several years to implement. Consequently, we will probably continue to see occasional shortages of vaccines in the United States in the next few years." papers.ssrn.com

To: TimF who wrote (528714)	11/13/2009 1:21:27 PM
From: tejek	Read Replies (1) \| Respond to of 1575913

Under Murdoch, the WSJ has become filled with ideological bile........now here's the truth: "But the October shortfall was not the first. Indeed, since the outbreak of the H1N1 swine flu occurred in April, federal projections have been consistently and wildly overoptimistic and have had to be ratcheted down several times. As recently as late July, the government was predicting having 160 million doses by this month. The reasons for the receding estimates start with the fact that the H1N1 virus, known as swine flu, is not growing as fast as expected in the eggs used to produce vaccine. Moreover, some manufacturers did not even know how little they were producing until a vaccine potency test became available around August, federal officials say. Some companies hit bottlenecks in putting the vaccine into vials and syringes. And an Australian company, CSL Ltd., satisfied its own country’s needs first. Federal officials argue, and some outside experts agree, that the government did a good job in rapidly marshaling suppliers of vaccine for the flu pandemic. The first doses were administered early this month, faster than in any other countries except China and Australia. And inoculations started only about five months after the swine flu outbreak started in Mexico, which is quicker than it takes to get a seasonal flu vaccine ready. nytimes.com